|
|
脂肪因子与子宫内膜癌关系的研究进展 |
张丽倩1, 毛淑芳2 |
1.河北省唐山市妇幼保健院妇科, 河北 唐山 063000 2.承德医学院预防医学教研室, 河北 承德 067000 |
|
[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].Ca Cancer Clin,2021,71(3):209-249. [2] Mili N,Paschou SA,Goulis DG,et al.Obesity,metabolic syndrome,and cancer:pathophysiological and therapeutic associations[J].Endocrine,2021,74(3):478-497. [3] Raglan O,Kalliala I,Markozannes G,et al.Risk factors for endometrial cancer:an umbrella review of the literature[J].Int Cancer,2019,145(7):1719-1730. [4] Lee CH,Woo YC,Wang Y,et al.Obesity,adipokines and cancer:an update[J].Clin Endocrinol (Oxf) 2015,83(2):147-156. [5] Scherer PE,Williams S,Fogliano M,et al.A novel serum protein similar to C1q,produced exclusively in adipocytes[J].Biol Chem,1995,270(45):26746-26749. [6] de Gennaro G,Palla G,Battini L,et al.The role of adipokines in the pathogenesis of gestational diabetes mellitus[J].Gynecol Endocrinol,2019,35(9):737-751. [7] Yunusova NV,Kondakova IV,Kolomiets LA,et al.Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)[J].Asia Pac Clin Oncol,2018,14(3):134-140. [8] Kim DS,Scherer PE.Obesity,diabetes,and increased cancer progression[J].Diabetes Metab,2021,45(6):799-812. [9] Ashizawa N,Yahata T,Quan J,et al.Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects[J].Gynecol Oncol,2010,119(1):65-69. [10] Wang Z,Gao S,Sun C,et al.Clinical significance of serum adiponectin and visfatin levels in endometrial cancer[J].Int Gynaecol Obstet,2019,145(1):34-39. [11] Zheng Q,Wu H,Cao J.Circulating adiponectin and risk of endometrial cancer[J].Plos One,2015,10(6):129824. [12] Dimou NL,Papadimitriou N,Mariosa D,et al.Circulating adipokine concentrations and risk of five obesity-related cancers:a mendelian randomization study[J].Int Cancer,2021,148(7):1625-1636. [13] Katira A,Tan PH.Evolving role of adiponectin in cancer-controversies and update[J].Cancer Biol Med,2016,13(1):101-119. [14] Hardie DG,Ross FA,Hawley SA.AMPK:a nutrient and energy sensor that maintains energy homeostasis[J].Nat Rev Mol Cell Biol,2012,13(4):251-262. [15] Yan Y,Shi H,Zhao Z,et al.Adiponectin deficiency promotes endometrial carcinoma pathogenesis and development via activation of mitogen-activated protein kinase[J].Pathol,2022,257(2):146-157. [16] Hayes MP,Wang H,Espinal-Witter R,et al.PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia[J].Clin Cancer Res,2006,12(20):5932-5935. [17] Yabushita H,Iwasaki K,Obayashi Y,et al.Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma[J].Oncol Lett,2014,7(4):1109-1117. [18] Hebbard LW,Garlatti M,Young LJ,et al.T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model[J].Cancer Res,2008,68(5):1407-1416. [19] Zhang Y,Proenca R,Maffei M,et al.Positional cloning of the mouse obese gene and its human homologue[J].Nature,1994,372(6505):425-432. [20] Kumar R,Mal K,Razaq MK,et al.Association of leptin with obesity and insulin resistance[J].Cureus,2020,12(12):e12178. [21] Wang PP,He XY,Wang R,et al.High leptin level is an independent risk factor of endometrial cancer:a meta-analysis[J].Cell Physiol Biochem,2014,34(5):1477-1484. [22] Shetty A,Venkatesh T,Tsutsumi R,et al.Gene expression changes and promoter methylation with the combined effects of estradiol and leptin in uterine tissue of the ovariectomized mice model of menopause[J].Mol Biol Rep,2020,47(1):151-168. [23] Daley-Brown D,Harbuzariu A,Kurian AA,et al.Leptin-induced notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance[J].World Clin Oncol,2019,10(6):222-233. [24] Zou S,Tong Q,Liu B,et al.Targeting STAT3 in cancer immunotherapy[J].Mol Cancer,2020,19(1):145. [25] Daley-Brown D,Oprea-Ilies GM,Lee R,et al.Molecular cues on obesity signals,tumor markers and endometrial cancer[J].Horm Mol Biol Clin Investig,2015,21(1):89-106. [26] Seldin MM,Peterson JM,Byerly MS,et al.Myonectin (CTRP15),a novel myokine that links skeletal muscle to systemic lipid homeostasis[J].BIOL CHEM,2012,287(15):11968-11980. [27] Kong M,Gao Y,Guo X,et al.Role of the CTRP family in tumor development and progression[J].Oncol Lett,2021,22(4):723. [28] Liao X,Liu S,Tang X,et al.Circulating CTRP6 levels are increased in overweight or obese Chinese individuals and associated with insulin resistance parameters:a pilot study[J].Exp Clin Endocrinol Diabetes,2021,129(7):535-541. [29] Lei X,Seldin MM,Little HC,et al.C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance[J].Biol Chem,2017,292(36):14836-14850. |
[1] |
刘雪洁, 李晓妍, 张凤. 基于ROCK-2/Moesin信号通路探究下调SIP1对子宫内膜癌细胞凋亡侵袭迁移的影响[J]. 河北医学, 2023, 29(3): 364-369. |
[2] |
任超, 张勇, 梁家立, 张波, 郑德志. 脂联素发挥生物学效应的信号传导机制[J]. 河北医学, 2022, 28(1): 173-176. |
[3] |
黄莉娜, 许书慧, 钟绍金, 李赛莲. 奥美拉唑钠联合西咪替丁治疗老年消化性溃疡疗效及对患者血清中Ghrelin和Leptin水平的影响[J]. 河北医学, 2021, 27(8): 1389-1394. |
[4] |
张晋, 姜英, 李文娟, 白枫. 子宫内膜癌组织中L1CAM Mel-18 c-myc的表达及临床意义[J]. 河北医学, 2021, 27(2): 238-241. |
[5] |
拜翠莲, 李昭, 史晓玲. 血清APN leptin及8-OHdG水平与小儿癫痫发作及认知损害的关系[J]. 河北医学, 2020, 26(9): 1425-1429. |
[6] |
符日明, 陈运旺, 雷智贤, 梁振明. 小儿厌食症患儿外周血神经肽Y胆囊收缩素 LEP水平测定及临床意义[J]. 河北医学, 2020, 26(9): 1499-1504. |
[7] |
郭玮, 刁海丹. 序贯放化疗对晚期子宫内膜癌患者术后辅助治疗疗效及血清HE4 CA125水平的影响[J]. 河北医学, 2020, 26(7): 1104-1106. |
[8] |
马旃, 雷海玲, 孙华毅. 老年高血压患者血清UA CK Cys-C APN水平与颈动脉粥样硬化之间的关系[J]. 河北医学, 2020, 26(5): 755-758. |
[9] |
庄新荣, 李淑梅, 张桂香. 联合吲哚菁绿和亚甲蓝示踪前哨淋巴结在子宫恶性肿瘤开腹手术中的意义[J]. 河北医学, 2020, 26(5): 796-800. |
[10] |
张弢, 于扬, 隋淼, 许静宜, 杨晓辉. 甲亢患者血清瘦素脂联素水平与甲状腺激素和骨代谢指标的关系[J]. 河北医学, 2020, 26(1): 28-32. |
[11] |
王晓华, 景阳, 付久园, 肖艳平, 韩冰, 赵鲁文, 张玉娟, 朱艳菊. Artemin CXCL13 MMP-9在子宫内膜癌组织中的表达及临床意义[J]. 河北医学, 2019, 25(9): 1480-1484. |
[12] |
安欣, 崔志利, 魏娉, 杨学丽, 尹峰. 环状RNA ciRS-7和EGFR在子宫内膜癌组织中的表达水平[J]. 河北医学, 2019, 25(8): 1321-1324. |
[13] |
胡文华, 王伟伟. 拜糖平联合利拉鲁肽治疗2型糖尿病的疗效 及对血清Hcy APN的影响[J]. 河北医学, 2019, 25(4): 590-593. |
[14] |
江勇, 谭卫林, 韩潞, 刘兵, 韩东兴. 结直肠癌患者血清脂联素瘦素及其受体表达与临床病理参数的关系[J]. 河北医学, 2018, 24(7): 1121-1124. |
[15] |
刘敏,王兆鹏,冯玉梅,杨新宏,孙常铭,张萍. 瘦素超敏C反应蛋白在糖耐量减低并睡眠障碍患者中的临床意义[J]. 河北医学, 2018, 24(10): 1672-1676. |
|
|
|
|